– USA, IL – Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Tom Polen to its Board of Directors, bringing more than 25 years of experience advancing healthcare solutions and technologies to the board.
“I am pleased to welcome Tom to the WBA Board of Directors. I know his industry insights and leadership will be a great asset as we advance local healthcare and wellbeing to deliver sustainable value to our customers, communities, partners, and shareholders,” said Executive Chairman, Stefano Pessina.
Tom Polen will also join the Finance and Technology Committee.
About Tom Polen
Tom Polen is the chairman, CEO, and president of BD (Becton, Dickinson, and Company), one of the world’s largest medical technology companies. Before his current role, Polen held several leadership positions within the company, including president and COO, president of the BD Medical segment, and president of several worldwide business units within BD’s Life Sciences segment.
Since beginning his career at BD in 1999, Tom Polen has made significant contributions to the company, including the transformation of BD’s portfolio into higher growth and more impactful markets. He led BD through several strategic moves including the $12 billion acquisition of CareFusion, a medication management and patient safety solutions provider, and also spearheaded the company’s expansion into informatics and digital health solutions. In 2017, he led the company’s strategy for the $24 billion acquisition of interventional technologies manufacturer C. R. Bard, Inc. Shortly after that, he was named president and COO of BD and later became CEO in January 2020. He was appointed chairman of BD’s board of directors in April 2021.
As CEO, Tom Polen has transformed BD into a highly innovative and technology-driven MedTech leader enabling the next generation of care through its focus on digital and automated solutions. The company is accelerating growth through a strengthened research and development pipeline, active portfolio management, and a robust simplification strategy that allows for prioritized investment in higher-impact areas.
Tom Polen said, “I’ve centered my career around working at and with companies that are making a positive impact on the lives of patients around the world and creating value for all stakeholders. Building on this passion, I look forward to joining the WBA Board of Directors and contributing to a company that has the potential to play a growing role in advancing and transforming the healthcare ecosystem and its shift into new care settings.”
Tom Polen also serves on the boards of directors of AdvaMed, where he chairs the Committee on Payment & Health Care Deliver Policy, and Hackensack Meridian Health Center for Discovery and Innovation, a subsidiary of Hackensack Meridian Medical Center. He is an American Heart Association CEO Roundtable member and serves on the U.S. Department of Commerce’s Advisory Committee on Supply Chain Competitiveness and its Manufacturing Competitiveness Subcommittee.
Tom Polen holds a bachelor’s degree from Salisbury University in Maryland and a Master of Business Administration from Johns Hopkins University.
About Walgreens Boots Alliance
Walgreens Boots Alliance is an integrated healthcare, pharmacy, and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.
A trusted, global innovator in retail pharmacy with approximately 13,000 locations across the U.S., Europe, and Latin America, WBA plays a critical role in the healthcare ecosystem. The Company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high-quality health and beauty products, and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.
WBA employs more than 325,000 people and has a presence in nine countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico, and Ahumada in Chile. Additionally, WBA has a portfolio of healthcare-focused investments in several countries, including China and the U.S.
The Company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace, and a sustainable marketplace. WBA has been recognized for its commitment to operating sustainably: the Company is an index component of the Dow Jones Sustainability Indices and was named to the 100 Best Corporate Citizens 2022.
For more information: https://www.walgreensbootsalliance.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.